Numerous human cancers have been shown to be associated with aberrant IGF signal pathways, including colorectal cancer, breast cancer, lung cancer, pancreatic cancer, melanoma, and childhood cancers, among many others [27]. Here, IGF1 is linked to lung carcinoma.